Genexis Biotech secures Rs 4 Cr Seed funding for biomanufacturing dominance

Investorsync desk1 min read

Deal sheet

Rs 4 Cr

Stage
Seed
Sector
BioTech
Announced
29 July 2025

Genexis Biotech has raised Rs 4 crore in seed funding led by GVFL, with participation from Benzai10 Investment Ventures Private Limited.

Founded by Vipul Kumar in 2019, Vadodara, Gujarat.

Genexis Biotech is building a cutting-edge biomanufacturing company that produces high-quality, animal-free proteins through recombinant technology and precision fermentation, serving industries such as biopharma, regenerative medicine, cell culture media, and cultivated meat.

The fresh capital will be used to expand bioreactor capacity, set up downstream processing infrastructure, launch new recombinant proteins and enzymes, and boost compliance, sales, and distribution capabilities.

  • Expanded portfolio to include recombinant growth factors, peptidases, and cell culture reagents.
  • Certified Class 10,000 manufacturing facility operational with a GMP-compliant unit in pipeline.

Source: company announcement. First posted on the Investorsync LinkedIn page.

From InvestorDB

Investors in this round.

Keep reading

The Sync Report

All Rounds